PHARMA MAR, S.A. «...1112131415...» Page 11 out of 22 28/04/2022 19:00 PHARMA MAR, S.A. Other relevant information The Executive Committee of Pharma Mar, S.A. has decided to implement the Free of Charge Stock Ownership Plan approved by resolution of the General Shareholders’ Meeting of 15 April 2021. Register number: 15904 28/04/2022 17:38 PHARMA MAR, S.A. On business and financial situation The Company files first quarter 2022 financial information. Register number: 15890 08/04/2022 08:28 PHARMA MAR, S.A. On credit ratings Axesor maintains long-term credit rating of Pharma Mar. Register number: 15513 07/04/2022 17:40 PHARMA MAR, S.A. Liquidity and counterparty agreements The Company reports details of the operations of the Liquidity Agreement between 01/01/2022 and 31/03/2022 Register number: 15504 01/04/2022 08:27 PHARMA MAR, S.A. On business and financial situation The Company sends press release announcing that Sylentis, a subsidiary of Pharma Mar, initiates a new Phase III trial in the United States to evaluate the safety of tivanisiran in patients with dry eye disease. Register number: 15345 23/03/2022 10:41 PHARMA MAR, S.A. Board of Directors Regulations La sociedad remite el reglamento del Consejo de Administración Register number: 15122 28/02/2022 21:24 PHARMA MAR, S.A. Annual financial reports and audit reports La sociedad remite el Informe Financiero Anual del ejercicio 2021 Register number: 14694 28/02/2022 18:01 PHARMA MAR, S.A. Annual report on directors´ remunerations La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2021 Register number: 14634 28/02/2022 18:01 PHARMA MAR, S.A. Annual corporate governance report La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2021 Register number: 14632 28/02/2022 17:52 PHARMA MAR, S.A. Other relevant information - On business and financial situation - On corporate governance The Company reports draw up of the Annual Financial Statements 2021, a proposal for a dividend, an amendment to the Board of Directors Regulations, and a conference call with analysts and investors. Register number: 14625 Page 11 out of 22 «...1112131415...»
